20-Nov-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Biology
Pharmacology & D...
Molecular Pharma...
Browse
ALL OF BIOLOGY
Pharmacology & Drug Discovery
Antimicrobial Agents
Cancer Therapeutics
Cardiovascular Pharmacology
Drug Discovery & Design
Endocrine & Metabolic Pharmacology
Gastrointestinal Pharmacology
Genito-Urinary & Reproductive Pharmacology
Immunopharmacology & Hematologic Pharmacology
Molecular Pharmacology
Musculoskeletal & Dermatologic Pharmacology
Neuropharmacology & Psychopharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Renal Pharmacology
Respiratory Pharmacology
Toxicology
Related Sections
Bioinformatics
Biomacromolecule-Ligand Interactions
Cell Signalling
Cell Signalling & Trafficking Structures
Chemical Biology of the Cell
Directed Molecular Evolution
Genomics
Macromolecular Chemistry
Medical Genetics
Physiogenomics
Protein Chemistry & Proteomics
Small Molecule Chemistry
selected for
My F1000 Biology
Browse > Pharmacology & Drug Discovery > Molecular Pharmacology
Top 10
/
All time Top 10
/
Most viewed
/
Hidden jewels
Page 1 of 25. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
confirmations
controversial
dissenting
drug target
hypotheses
new findings
refutation
tech advances
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T, Lou J, …, McEver RP, Zhu C
J Clin Invest
2008 Sep
118
(9):3195-207 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Xiaoping Du
Evaluated 20 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Structure-activity relationships study of bastadin 6, an anti-angiogenic brominated-tyrosine derived metabolite from marine sponge.
Kotoku N, Hiramatsu A, …, Aoki S, Kobayashi M
Arch Pharm (Weinheim)
2008 Sep
341
(9):568-77 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Tadeusz Molinski
Evaluated 18 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS, Cha EY, …, Yeo CW, Shin JG
Hepatology
2008 Aug
48
(2):635-45 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Bruno Stieger
Evaluated 18 Nov 2008
Recommended
F1000 Factor
3.0
Controversial
The involvement of urothelial alpha1A adrenergic receptor in controlling the micturition reflex.
Yanase H, Wang X, …, Nimura T, Kawatani M
Biomed Res
2008 Oct
29
(5):239-44 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Rodolfo Testa with Patrizia Angelico
Evaluated 18 Nov 2008
Recommended
F1000 Factor
3.0
Tech Advance
Novel Drug Target
Generating Arrays with High Content and Minimal Consumption of Functional Membrane Proteins.
Majd S, Mayer M
J Am Chem Soc
2008 Nov 1
0
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Ross Weatherman
Evaluated 17 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
PirB is a functional receptor for myelin inhibitors of axonal regeneration.
Atwal JK, Pinkston-Gosse J, …, Shatz C, Tessier-Lavigne M
Science
2008 Nov 7
322
(5903):967-70 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Susan K. McConnell
Evaluated 14 Nov 2008
Must Read
F1000 Factor
6.0
New Finding
Tech Advance
Anatomical profiling of G protein-coupled receptor expression.
Regard JB, Sato IT, Coughlin SR
Cell
2008 Oct 31
135
(3):561-71 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Soeren Sheikh
Evaluated 14 Nov 2008
Must Read
F1000 Factor
6.0
Hypothesis
Refutation
Novel Drug Target
Anionic charge is prioritized over geometry in aluminum and magnesium fluoride transition state analogs of phosphoryl transfer enzymes.
Baxter NJ, Blackburn GM, …, Wemmer DE, Waltho JP
J Am Chem Soc
2008 Mar 26
130
(12):3952-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Arieh Warshel with Shina Caroline Lynn Kamerlin
Evaluated 13 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.
Jackson NE, Wang HW, …, Cairns J, Hunt JE
J Biol Chem
2008 Oct 14 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Richard L. Stevens
Evaluated 13 Nov 2008
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Agonist-selective, Receptor-specific Interaction of Human P2Y Receptors with {beta}-Arrestin-1 and -2.
Hoffmann C, Ziegler N, …, Krasel C, Lohse MJ
J Biol Chem
2008 Nov 7
283
(45):30933-41 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ralf Jockers with Maud Kamal
Evaluated 13 Nov 2008
top of page
Page 1 of 25. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
© 1999-2008 Biology Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info